InHealth, the UK’s largest specialist provider of diagnostic and healthcare solutions, has announced a partnership with Qure.ai, a market leader in medical artificial intelligence (AI) solutions. Through this partnership, InHealth will be deploying Qure.ai‘s AI solution to aid in the classification of chest X-rays into conventional and unconventional exams. The solution will be deployed across InHealth’s entire Tele-reporting service arm to help enhance the quality and accuracy of reporting using AI.
Back
Jonny McDaniell, Director of Operations – Reporting at InHealth, said: “We are excited to be partnering with Qure.ai to deploy qXR AI software into our tele-radiology platform to assist physicians in highlighting life-threatening health markers and improve reporting time for critical cases.”
Qure.ai‘s EU MDR CE Class IIb – certified chest X-ray solution, qXR, will help identify which cases are clear of clinically relevant findings, enabling radiologists to read them more accurately within minutes. With Qure’s qXR in place, InHealth is pleased to be driving efficiency and quality in its reads, enabling them to better support clients in tackling chest X-ray (CXR) backlog challenge. It will also help InHealth to prioritise more clinically urgent cases.
Speaking about the partnership, Darren Stephens, Senior Vice President & Commercial Head UK and Europe of Qure.ai, said, “Our partnership with InHealth is a validation to our dominance in the UK radiology AI market. By combining our expertise in medical imaging with InHealth’s commitment to delivering high-quality diagnostic services, we can make a significant impact on patient outcomes. Together, we can advance the frontiers of healthcare and improve the lives of people across the UK.”
Qure.ai‘s chest X-ray software can detect multiple lung markers in under one minute. It can accurately assess radiological findings presumptive of a host of lung diseases, including lung cancer, pneumonia, COPD, TB, and heart failure, among others.
